Inventor
LUO GUANGLIN
US41 patents
⚠️ This page may combine multiple inventors who share the name “LUO GUANGLIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
28 patentsUS9902722B2Feb 27, 2018
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO19 citations94
US6916812B2Jul 12, 2005
Alpha-aminoamide derivatives as melanocortin agonists
BRISTOL MYERS SQUIBB CO23 citations92
US10550080B2Feb 4, 2020
Acyl sulfonamide NaV1.7 inhibitors
BRISTOL MYERS SQUIBB CO8 citations84
US10351563B2Jul 16, 2019
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US10155760B2Dec 18, 2018
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US8044043B2Oct 25, 2011
CGRP receptor antagonists
BRISTOL MYERS SQUIBB CO12 citations84
US7569578B2Aug 4, 2009
Heterocyclic anti-migraine agents
BRISTOL MYERS SQUIBB CO14 citations84
US10913738B2Feb 9, 2021
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations83
US7842808B2Nov 30, 2010
Anti-migraine spirocycles
BRISTOL MYERS SQUIBB CO13 citations83
US7314883B2Jan 1, 2008
Anti-migraine treatments
BRISTOL MYERS SQUIBB CO12 citations83
US7220862B2May 22, 2007
Calcitonin gene related peptide receptor antagonists
BRISTOL MYERS SQUIBB CO11 citations81
US10723734B2Jul 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US10752609B2Aug 25, 2020
GSK-3 inhibitors
BRISTOL MYERS SQUIBB CO6 citations72
US9718804B2Aug 1, 2017
GSK-3 inhibitors
BRISTOL MYERS SQUIBB CO5 citations72
US11767322B2Sep 26, 2023
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations70
US12157733B2Dec 3, 2024
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US12065437B2Aug 20, 2024
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US11440913B2Sep 13, 2022
Aminoimidazopyridazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US11053258B2Jul 6, 2021
Pyrimidine carboxamides as GSK-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US10981910B2Apr 20, 2021
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US10544120B2Jan 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US12110290B2Oct 8, 2024
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US7049323B2May 23, 2006
Amidoheterocycles as modulators of the melanocortin-4 receptor
BRISTOL MYERS SQUIBB CO2 citations61
US12172975B2Dec 24, 2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
BRISTOL MYERS SQUIBB CO0 citations52
US11618753B2Apr 4, 2023
Aminopyrrolotriazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7470680B2Dec 30, 2008
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO1 citations51
US9809573B2Nov 7, 2017
Substituted pyridine derivatives useful as GSK-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
UNIV STANFORD
5 patentsUS6080555AJun 27, 2000
Synthesis of polyketides from diketides
UNIV STANFORD59 citations95
US6066721AMay 23, 2000
Method to produce novel polyketides
UNIV STANFORD70 citations95
US6531299B1Mar 11, 2003
Cell-free synthesis of polyketides
UNIV STANFORD17 citations92
US6261816B1Jul 17, 2001
Method to produce novel polyketides
UNIV STANFORD6 citations73
US6710189B2Mar 23, 2004
Method to produce novel polyketides
UNIV STANFORD1 citations62